Colin Dinney, MD

Colin P.N. Dinney, MD, is the chairman of the Department of Urology, Division of Surgery, The University of Texas MD Anderson Cancer Center in Houston.

Articles by Colin Dinney, MD

uGDB Predicts Response to Cretostimogene in BCG-Unresponsive NMIBC

ByColin Dinney, MD

May 10th 2025

Colin P.N. Dinney, MD, provides some background on translational analyses from the BOND-003 and CORE-001 trials.

Predicting Cretostimogene Grenadenorepvec Response With Urinary Genomics

ByColin Dinney, MD

April 26th 2025

Colin P.N. Dinney, MD, discusses updated translational analyses from the BOND-003 and CORE-001 trials.

Latest Updated Articles

Predicting Cretostimogene Grenadenorepvec Response With Urinary Genomics
Published: April 26th 2025 | Updated:

Colin Dinney, MD

Articles by Colin Dinney, MD

uGDB Predicts Response to Cretostimogene in BCG-Unresponsive NMIBC

Predicting Cretostimogene Grenadenorepvec Response With Urinary Genomics

Latest Updated Articles

Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways

FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL

Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC

Safusidenib Shows Robust, Ongoing Responses in Grade 2 IDH1-Mutant Glioma

Sac-TMT Demonstrates Antitumor Activity, Safety in Urothelial Carcinoma

LP-184 Demonstrates Favorable Efficacy and Safety in Advanced Solid Tumors